Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 3/20 | 0.46 |
| ▸ | ATIC | P31939 | 1/20 | 0.39 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.38 |
| ▸ | LDHA | P00338 | 2/20 | 0.38 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | DNPH1 | O43598 | 2/20 | 0.37 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.37 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | SRC | P12931 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.37 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.37 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18118154 | 0.76 | FBP1 (0.46) | FBP1ATICP2RY2LDHAP2RY6 | |
| SCHEMBL18350031 | 0.76 | FBP1 (0.46) | FBP1ATICP2RY2LDHAP2RY6 | |
| SCHEMBL18118157 | 0.76 | FBP1 (0.46) | FBP1ATICP2RY2LDHAP2RY6 | |
| SCHEMBL18350026 | 0.76 | FBP1 (0.46) | FBP1ATICP2RY2LDHAP2RY6 | |
| SCHEMBL15305518 | 0.76 | FBP1 (0.46) | FBP1ATICP2RY2LDHAP2RY6 | |
| SCHEMBL25843161 | 0.74 | POLB (0.38) | P2RY2P2RY6 | |
| SCHEMBL15722784 | 0.73 | FBP1 (0.48) | FBP1ATICP2RY2P2RY6DNPH1 | |
| SCHEMBL18963500 | 0.70 | TRPM2 (0.38) | P2RY2P2RY6TRPM2SRCP2RY1 | |
| SCHEMBL18963501 | 0.70 | TRPM2 (0.38) | P2RY2P2RY6TRPM2SRCP2RY1 | |
| SCHEMBL17001181 | 0.70 | TRPM2 (0.38) | P2RY2P2RY6TRPM2SRCP2RY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219994-A1 | MODIFIED NUCLEOSIDE AND SYNTHESIS METHOD THEREFOR | Stemirna Therapeutics Co., Ltd. (CN) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219994-A1 | MODIFIED NUCLEOSIDE AND SYNTHESIS METHOD THEREFOR | RNMT, RNGTT, BCDIN3D | FBP1 965/4885ATIC 45/4885P2RY2 3959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.